| 000 | 01406 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515111115.0 | ||
| 264 | 0 | _c20080909 | |
| 008 | 200809s 0 0 eng d | ||
| 022 | _a0952-1941 | ||
| 024 | 7 |
_a10.1017/S0265021507003213 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCattaneo, M | |
| 245 | 0 | 0 |
_aHaemorrhagic stroke during anti-platelet therapy. _h[electronic resource] |
| 260 |
_bEuropean journal of anaesthesiology. Supplement _c2008 |
||
| 300 |
_a12-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAcute Coronary Syndrome _xchemically induced |
| 650 | 0 | 4 |
_aAspirin _xadverse effects |
| 650 | 0 | 4 | _aCerebral Hemorrhage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntracranial Hemorrhages _xchemically induced |
| 650 | 0 | 4 | _aPlatelet Activation |
| 650 | 0 | 4 | _aPlatelet Aggregation |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xmetabolism |
| 650 | 0 | 4 | _aPurinergic P2 Receptor Antagonists |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVitamin K _xantagonists & inhibitors |
| 773 | 0 |
_tEuropean journal of anaesthesiology. Supplement _gvol. 42 _gp. 12-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1017/S0265021507003213 _zAvailable from publisher's website |
| 999 |
_c17793573 _d17793573 |
||